4 Biotech Penny Stocks to Watch Right Now
As you put together a penny stock watchlist for the month of June you might want to keep in mind what news could come out during the month. The biotech industry is well-known for releasing news often. This can occur prior to a new compounds rollout or the results of a trial.
Because biotech penny stocks are required to release findings from studies so often, they are known to fluctuate greatly in price. This makes investing in these penny stocks, highly speculative, which is something to keep in mind. Additionally, investors can benefit from the rapid price movements, by understanding how to trade penny stocks and how to benefit from large intraday swings.
Investing in Biotech Penny Stocks
The FDA requires several phases to be completed per trial for each drug or device before it is approved. This is good news for investors because it means a lot of news can shift prices and investor interest along the way.
However, for some companies, this process can take years, which is not only costly but time-consuming as well. Recently, companies like Pfizer Inc. (NYSE: PFE), and Moderna Inc. (NASDAQ: MRNA) were granted rapid approvals due to the COVID-19 pandemic, yet this is not typically the case.
Typically early release of news leads to large price volatility, this is especially true when considering penny stocks under $5. If good news is released, the stock may see large intraday gains, however, a bad result can lead to a steep fall.
This is because most penny stocks are relatively small and as mentioned before, highly speculative. As investors, this is why it’s crucial to do a full analysis of the business before buying in.[Read More] Top Penny Stocks to Buy? Check These 4 Out For Your May Watchlist
This can include looking over its financials, past earnings, product pipeline, and new changes to the board of directors, among other factors. Earnings tell us if the company is profitable, or if it’s working towards profitability.
Many compare past earnings to expected ones based on analysts’ reviews. A product pipeline shows us what a biotech penny stock is working on. This can be indicative of where it’s devoting its resources as well as what investors can expect.
With all of this in mind, when thinking about biotech penny stocks to buy, having a thorough understanding of what the company does will always be paramount to your success.
At the end of the day, research and a concrete trading method will help to give your portfolio a better chance of seeing profits. Here are four intriguing biotech penny stocks to add to your June watchlist.
4 Biotech Penny Stocks You Should Keep An Eye On
- Advaxis, Inc. (NASDAQ: ADXS)
- T2 Biosystems Inc. (NASDAQ: TTOO)
- Tyme Technologies Inc. (NASDAQ: TYME)
- Sesen Bio Inc. (NASDAQ: SESN)
1. Advaxis Inc. (NASDAQ: ADXS)
Advaxis is a clinical-stage biotech company. It operates and specializes in the research and development of novel Listeria monocytogenes (Lm)-based antigen delivery products. This is an emerging field in the biotech industry. These products are considered immunotherapies that utilize Lm bioengineering to produce antigen fusion proteins.
This recent advancement has implications in immunotherapies, as it can combine multiple treatments into one. By allowing more direct access to antigens and activating the correct immune response with multiple adjuvants, it enables our T cells to help eradicate tumor progression.
Cancer is diverse and extremely detrimental. Many companies are developing targeted therapies for specific types using a variety of different innovative methods. ADXS is no different and it is currently in Phase 1/2 of testing with ADXS-503 in combination with KEYTRUDA. This is for early intervention against prostate cancer.
“We are encouraged by these updated results which continue to support the potential of ADXS-503 to enhance and/or restore sensitivity to checkpoint inhibitors.
The clinical activity observed to date in this challenging patient population, combined with a favorable safety profile, suggests that ADXS-503 may be an important new off-the-shelf immunotherapy treatment option.
We look forward to continued progress in the clinic with our ADXS-HOT products which include the ongoing Phase 1/2 study of ADXS-503 in NSCLC, and the expansion of the program to our planned Phase 1 Study of ADXS-504 for the treatment of early prostate cancer.”CEO of Advaxis, Ken Berlin
Considering all of this news, will you add ADXS to your list of penny stocks to watch?
2. T2 Biosystems Inc. (NASDAQ: TTOO)
A biotech penny stock we have covered many times recently is T2 Biosystems. As another biotech company, T2 still has to go through a variety of trials, despite it not producing a pharmaceutical compound.
Its specialty is in resonance imagining, meant to rapidly diagnose septic problems. TTOO also has a strong pipeline that is developing different panel tests for other ailments. This includes the T2Cauris panel, T2Resistance panel, and T2Lyme panel.
In the past week, TTOO has seen a gain of 5%, finally showing a glimpse of bullish momentum to investors. Penny stocks, just like everything else, go through periods of consolidations and corrections.[Read More] 5 Penny Stocks Analysts Say To Buy With Targets Up To 219% Right Now
The first-quarter earnings for instance returned a 173% growth in its top-line numbers YoY, yet, shares of TTOO declined after this was announced. This occurs on occasion as a result of high speculation and uncertainty about a company’s future. The positive news, however, helps in this situation, but again, penny stocks are sometimes unpredictable.
As the US healthcare system puts more priority on early diagnosis to implement early intervention strategies, TTOO is in a good position in the coming future. Its strong product pipeline, as well as encouraging business updates, could make it worth watching? So, what do you think, is TTOO a watchlist candidate or not?
3. Tyme Technologies Inc. (NASDAQ: TYME)
Tyme Technologies is another emerging biotech company that is also in the research and development industry of cancer therapeutics. It focuses specifically on metabolism-based therapies, another pathway towards attempting to prevent and eliminate different tumor types. This new method of therapy is intended to take a broad look at the effectiveness of low toxicity treatments.
These therapies are unlike targeted ones, as it does not try to focus on specific cancer mutations, rather a higher level regulatory system. Specifically, it looks at the metabolic weakness of a cancer cell to initiate cell death through oxidative stress and exposure to the body’s natural environment.
Currently, the company has developed TYME-18 and TYME-19 as its staple products. However, it believes that its new advancements in bile acid therapies have implications for cancers and even viruses such as Sars-CoV-2. Considering this, Tyme Technologies is an interesting biotech penny stock to watch in 2021.
4. Sesen Bio Inc. (NASDAQ: SESN)
The last biotech penny stock on this list is Sesen Bio. As a late-stage clinical company, its focus is on targeting fusion protein therapeutics. Protein therapies in general target crucial components of cancer development and spread, which can be extremely effective in treatment.
This is a company that is currently in Phase 3 of its lead product Vicineum, a drug intended for BCG-unresponsive non-muscle invasive bladder cancer (NMIBC). Vicineum is administered locally using a targeted fusion protein that is constructed by conjugating an anti-EpCAM antibody fragment to a Pseudomonas Exotoxin A. This target cell surface antigen has limited expression on normal cells, meaning that it can be an effective target for protein therapies.[Read More] Penny Stocks And Cryptocurrency, Which Small-Caps Should You Watch?
Recently, SESN has joined forces with Qilu Pharmaceutical and Hikma Pharmaceuticals for future drug commercialization. This preparation for drug rollout is indicative of its goal-oriented mindset and future intention.
Partnerships in the biotech industry are extremely important. They allow for collaboration and the potential to get a compound or technology to the public sooner than doing so alone.
Are Biotech Penny Stocks Worth It?
As the biotech industry continues to make advancements in our world, it’s important to always keep an eye out for new developments. Biotech penny stocks specifically offer investors a lot of opportunities for profit, as each successful stage can lead to incredible growth.
- 7 Penny Stocks On Robinhood To Watch In June 2021
- Reddit Penny Stocks You Might’ve Missed In May 2021
Risk should always be taken into consideration, and research is crucial before investing. What do you think of this list of penny stocks? What other biotech penny stocks are you adding to your watchlist for this upcoming month?